risk sharing

News
High Risk of Preventable and Mitigable Adverse Events in Cancer Care
08/22/2017
JCP Editors
Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...
Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...
...
08/22/2017
Journal of Clinical Pathways
Research in Review
CML Treatment Decisions Should Factor in Cardiovascular Disease Risk
07/27/2017
JCP Editors
Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...
Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...
...
07/27/2017
Journal of Clinical Pathways
Research in Review
Increased Risk of Secondary Cancer for Survivors of Hodgkin Lymphoma
05/19/2017
JCP Editors
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma
05/19/2017
JCP Editors
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A...
05/19/2017
Journal of Clinical Pathways
Research in Review
Mutations in CLL Cells May Be Used as Biomarker for Future Relapse
05/09/2017
JCP Editors
Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...
Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...
...
05/09/2017
Journal of Clinical Pathways
Research in Review
Shorter Course of Radiation Therapy After Mastectomy Deemed Safe and Effective
05/08/2017
JCP Editors
A radiation schedule half the standard course is as safe and effective for patients with breast cancer following a mastectomy, according to a study published in the Journal of Clinical Oncology (published...
A radiation schedule half the standard course is as safe and effective for patients with breast cancer following a mastectomy, according to a study published in the Journal of Clinical Oncology (published...
A...
05/08/2017
Journal of Clinical Pathways
Research in Review
Flu Vaccine May Cause Adverse Events for Lung Cancer Patients on Immunotherapy
05/03/2017
JCP Editors
Patients with lung cancer who are treated with immunotherapy may be at increased risk of severe adverse events after receiving the seasonal influenza vaccination, according to results of a study presented at the...
Patients with lung cancer who are treated with immunotherapy may be at increased risk of severe adverse events after receiving the seasonal influenza vaccination, according to results of a study presented at the...
...
05/03/2017
Journal of Clinical Pathways
Research in Review
Ovarian Cancer Survival Influenced By Previous Comorbidities
05/02/2017
JCP Editors
Common comorbidities such as hypertension, heart disease, and diabetes may contribute to a woman’s prognosis after being diagnosed with ovarian cancer, according to a study published in Cancer Causes Control...
Common comorbidities such as hypertension, heart disease, and diabetes may contribute to a woman’s prognosis after being diagnosed with ovarian cancer, according to a study published in Cancer Causes Control...
Common...
05/02/2017
Journal of Clinical Pathways
Research in Review
Removing Metastases Improves Survival for Patients With Kidney Cancer
04/28/2017
JCP Editors
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
...
04/28/2017
Journal of Clinical Pathways
Research in Review
Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma
04/27/2017
JCP Editors
Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...
Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...
...
04/27/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use